drugset / Trial / NCT03983967
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate and validate the maximum tolerated dose (MTD) or maximum available dose (MFD), safety and efficacy on patients with hepatocellular carcinoma beyond Milan criteria who undergo liver transplantation.
Timeline
- Start
- 2019-01-24
- Primary completion
- 2021-09-09
- Completion
- 2022-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immuncell-LC | Cell therapy | — | — |
Indications
No indication recorded.